Bromocriptine vs. Cabergoline
Bromocriptine and cabergoline are dopamine agonists used for hyperprolactinemia conditions like prolactinomas. Bromocriptine, with a shorter half-life, often requires frequent dosing, leading to gastrointestinal side effects. Cabergoline, preferred for its longer half-life, enables once or twice-weekly dosing, enhancing compliance and minimizing side effects.

